期刊文献+

阿司匹林预防心脑血管疾病的获益与风险 被引量:10

下载PDF
导出
作者 贾安
出处 《中国实用医药》 2010年第5期236-238,共3页 China Practical Medicine
  • 相关文献

参考文献20

  • 1李小鹰.阿司匹林在心血管疾病一级预防中的作用[J].中华医学杂志,2005,85(13):889-891. 被引量:15
  • 2Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs : the relationships among dose, effectiveness, and side effects : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest,2004,126(3 Suppl) :S 234-264.
  • 3Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atheroselerotic Vaseular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation,2002,106 (3) :388-391.
  • 4Parving HH. Hypertension Optimal Treatment (HOT) trial. Lancet, 1998,352(9127) :574-575.
  • 5Hermida RC, Ayala DE, Calvo C, et al. Aspirin administered at bed- time, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J Am Coll Cardiol, 2005,46 ( 6 ) : 975-983.
  • 6董军亚,赵玉娟.阿司匹林对血压的影响[J].中华老年多器官疾病杂志,2008,7(4):330-333. 被引量:6
  • 7高润霖.进一步加强阿司匹林在心脑血管疾病一级预防中的应用[J].医学研究杂志,2008,37(2):1-2. 被引量:14
  • 8Hayashino Y, Hennekens CH, Kurth T. Aspirin use and risk of type 2 diabetes in apparently healthy men. Am J Med ,2009,2,20.
  • 9Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med ,2005,352 ( 13 ) : 1293-1304.
  • 10规范应用阿司匹林治疗缺血性脑血管病的专家共识[J].中华内科杂志,2006,45(1):81-82. 被引量:76

二级参考文献75

  • 1朱佩华,杨菊华,李东辉,姚万青.阿司匹林对脑梗死患者血清C反应蛋白影响及抗血小板聚集作用的临床观察[J].中风与神经疾病杂志,2006,23(5). 被引量:7
  • 2郑书成,乔宝安,陈学风.阿斯匹林新用途与不良反应[J].中国新医药,2003,2(6):69-70. 被引量:5
  • 3Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
  • 4Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.The SALT Collaborative Group.Lancet,1991,338:1345-1349.
  • 5European Stroke Prevention Study 2.Efficacy and safety data.J Neurol Sci,1997,151 Suppl:S1-S77.
  • 6Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.EAFT (European Atrial Fibrillation Trial) Study Group.Lancet,1993,342:1255-1262.
  • 7Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
  • 8The International Stroke Trial (IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group.Lancet,1997,349:1569-1581.
  • 9CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.CAST (Chinese Acute Stroke Trial) Collaborative Group.Lancet,1997,349:1641-1649.
  • 10[1]Franz HM.Aspirin:a novel antihypertensive drug? Or two birds with one stone?J Am Coll Cardiol,2005,46:984-985.

共引文献641

同被引文献81

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部